On Tuesday, Artelo Biosciences Inc (NASDAQ: ARTL) was -38.00% drop from the session before settling in for the closing price of $3.0. A 52-week range for ARTL has been $3.00 – $28.60.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 27.29%. When this article was written, the company’s average yearly earnings per share was at 60.16%. With a float of $1.14 million, this company’s outstanding shares have now reached $1.15 million.
Artelo Biosciences Inc (ARTL) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Artelo Biosciences Inc stocks. The insider ownership of Artelo Biosciences Inc is 0.61%, while institutional ownership is 1.45%.
Artelo Biosciences Inc (ARTL) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -2.1 earnings per share (EPS) during the time that was better than consensus figure (set at -10.68) by 8.58. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 60.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 68.35% during the next five years compared to 27.29% growth over the previous five years of trading.
Artelo Biosciences Inc (NASDAQ: ARTL) Trading Performance Indicators
You can see what Artelo Biosciences Inc (ARTL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -19.05, a number that is poised to hit -0.82 in the next quarter and is forecasted to reach -0.74 in one year’s time.
Technical Analysis of Artelo Biosciences Inc (ARTL)
The latest stats from [Artelo Biosciences Inc, ARTL] show that its last 5-days average volume of 1.32 million was superior to 0.27 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 6.56%.
During the past 100 days, Artelo Biosciences Inc’s (ARTL) raw stochastic average was set at 0.07%, which indicates a significant decrease from 0.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.37 in the past 14 days, which was lower than the 1.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.00, while its 200-day Moving Average is $7.29. Now, the first resistance to watch is $2.36. This is followed by the second major resistance level at $2.86. The third major resistance level sits at $3.12. If the price goes on to break the first support level at $1.60, it is likely to go to the next support level at $1.34. The third support level lies at $0.84 if the price breaches the second support level.
Artelo Biosciences Inc (NASDAQ: ARTL) Key Stats
There are 704K outstanding shares of the company, which has a market capitalization of 2.13 million. As of now, sales total 0 K while income totals -9,830 K. Its latest quarter income was 0 K while its last quarter net income were -3,220 K.
